72 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
accounting firm;
reviews and approves the scope and plans for the audits and the audit fees and approves all non-audit and tax services … fees(1)
Audit-related fees(2)
Tax fees(3)
All other fees(4)
Total fees
Audit fees include fees incurred associated with the annual audit, the reviews
8-K
EX-10.1
efex1kgndjn4rhju66
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-10.1
fpv5uya99l6sa446
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
EX-10.2
y1tqw0sgirn0cfsn08w
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.3
tqbjdmf
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
uvf3dxyw
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.1
vwsxal9udj8gncb1f
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
DEFC14A
vl7tnt52
5 Apr 22
Proxy in contested solicitation
4:08pm